Bluish-gray fingernail discoloration due to the use of nivolumab.

Miguel Michel Ocampo Jaren Lerner Constantin A Dasanu

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)

To our knowledge, this is the first case report of an unusual bluish-gray nail discoloration due to therapy with nivolumab. The mechanism by which nivolumab causes this side effect remains to be elucidated.

Keyphrases

case report
healthcare
bone marrow
mesenchymal stem cells
smoking cessation